 |
PDBsum entry 2j4z
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
1,4,5,6-Tetrahydropyrrolo[3,4-C]pyrazoles: identification of a potent aurora kinase inhibitor with a favorable antitumor kinase inhibition profile.
|
 |
|
Authors
|
 |
D.Fancelli,
J.Moll,
M.Varasi,
R.Bravo,
R.Artico,
D.Berta,
S.Bindi,
A.Cameron,
I.Candiani,
P.Cappella,
P.Carpinelli,
W.Croci,
B.Forte,
M.L.Giorgini,
J.Klapwijk,
A.Marsiglio,
E.Pesenti,
M.Rocchetti,
F.Roletto,
D.Severino,
C.Soncini,
P.Storici,
R.Tonani,
P.Zugnoni,
P.Vianello.
|
 |
|
Ref.
|
 |
J Med Chem, 2006,
49,
7247-7251.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
The optimization of a series of 5-phenylacetyl
1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole derivatives toward the inhibition of
Aurora kinases led to the identification of compound 9d. This is a potent
inhibitor of Aurora kinases that also shows low nanomolar potency against
additional anticancer kinase targets. Based on its high antiproliferative
activity on different cancer cell lines, favorable chemico-physical and
pharmacokinetic properties, and high efficacy in in vivo tumor models, compound
9d was ultimately selected for further development.
|
 |
|
|
|
|
 |